NO Image

Biosimilars Summit 2021

March 22, 2021

|

Online Webinar









World Biosimilars and Biologics Summit 2021

LexisConferences is delighted to invite all to the upcoming World Biosimilars & Biologics Summit 2021 which is going to be held on March 22, 2020.

Biosimilars Summit 2021 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as Researchers, Analysts, Pharmacists, Pharmacovigilants,  Regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Young Investigators Forum, Special Sessions, Panel Discussions, Exhibitions, Poster Presentations, Workshop and Symposiums.

Biosimilars Summit 2021 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars, biologics, biopharmaceuticals and more. This conference will provide all our participants Business 2 Business sessions, where they will be able to reach out and make a mark for themselves globally.

The Global biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 4.49 Billion in 2017, at a CAGR of 31.7%. By far European Countries dominate the market owing to the favorable government regulations in this region representing 80% of global spending followed by USA which approximately covers around 50% global biologics market and coming to Asia it is expected that in the next 5 years global pharmaceutical spending will rise upto 43% from a roughly 38%.

References:  

                        Details of BIOSIMILARS AND BIOLOGICS SUMMIT 2021        

Conference Name Venue Dates
Biosimilars Summit 2021 Online Webinar March 22, 2021

Call for Submissions

Abstracts will be reviewed by the Abstract Review Board (ARB) of the conference

Lucy
Ha Kung Wong
Venable Fitzpatrick, USA

Biography

Ha Kung Wong practices general intellectual property law with an emphasis on complex patent and trade secret litigation as well as intellectual property transactions and contract negotiations for mergers, acquisitions, vendor agreements and collaborations in pharmaceuticals, biologics, chemistry and medical devices. Cases Ha Kung has litigated include those related to proton pump inhibitors, anti-epileptic drugs, anti-tussives, ADHD medications, injectable microspheres, RNAi products and other pharmaceuticals. Ha Kung also has extensive experience with inter partes review, post grant review, intellectual property counseling, pre-suit investigations, licensing and due diligence, including patent strength and freedom-to-operate analyses.

Researches :

  • Biosimilars, Pharmaceuticals, Biologics, Chemistry and medical devices
Lucy
Sophia Z Humphreys
St Joseph Health, USA

Biography

Dr. Humphreys is the Director of Pharmacy Clinical Services at Providence St. Joseph Health.  She earned her Doctorate in Pharmacy (Pharm.D.) from University of Washington and her Master of Health Administration (MHA) from University of Cincinnati.  She also serves a Clinical Assistant Professor at the School of Pharmacy, University of Washington. Dr. Humphreys has 20 years of for profit as well as non-profit experience in the pharmaceutical industry, including clinical research, formulary management, strategic planning, and operational management.  She is passionate about continuous quality improvement, financial sustainability and innovative care delivery methodologies. As the Providence St. Joseph Health System Pharmacy Clinical Service Director, she leads the system formulary management team and the medication utilization team which are responsible for managing a formulary consists of medications of an annual cost of 1.2 billion dollars.

Researches :

  • Biosimilar, medication utilization management, healthcare sustainability, cost reduction
Lucy
Motawa E El Houseini
Cairo Univeristy , Egypt

Biography

He is a Professor and Chairman of Cancer Biology Dept  .(1998 - 2001). His Professional Experience in Research Fellowship from DANIDA at Fibiger Laboratories, Finisin Institute, Copenhagen, Denmark  (1979 – 198- NIH Research Fellowship at Pittsburgh cancer institute, Transplantation institute& pathology dept. of Pittsburgh University USA.   (1993-1995).
Organizational/Managerial Experience: European Association of Cancer Research (EACR) -1980), International Affiliate Member of Institute of Cancer Research and (I.C.R), USA.(2000).
Academic Award: Cairo University Scientific Price (1996) and Masre El Khair Price (2012)

Researches :

  • Immunotherapy for Breast cancer as promisimg Fourth pilar in cancer treatment. Novel theory in cancer metastases and how to stop metastasis.
Lucy
Anupam Chanda
Alembic Pharmaceuticals, India

Biography

Anupam Chanda  has his expertise in  creating innovative design in packaging material and device for Biologics, biosimilar , anti Cancer and HIV products. He is having two decades( approx. 25 years) of experience in India and abroad. He is a renowned speaker , widely travel throughout the world. Gain and share his thoughts with scientist from various institution and industry professionals. Author’s Technical book “ Packaging Technology An advance Practical approach “Published from Germany and Amazon is distributing to 77 countries.

Researches :

  • Biologics, Biosimilar, anti Cancer and HIV products
Lucy
Alokkumar Bandyopadhyay
AB Consulting, USA

Biography

Alok Bandyopadhyay is a senior global consultant at AB consulting. He started his scientific career working on immunoglobulin and received his PhD from University of Calcutta. Afterwards, he came to USA to work on molecular biology of proteins using Fulbr

Researches :

  • Biological Sciences and Biosimilars
Lucy
Shorena Archuadze
Head of the Oncology Drug Development
JSC R-Pharm

Biography

I'm a board certified hematologist and oncologist, PhD in hematology. I have worked in pharmaceutical business for 11+ years including recent 2 years in the role of the head of oncology drug development. Within the range of business development responsibi

Researches :

  • Solid tumours, haematological malignancies, targeted therapy, biosimilars, immunooncology, drug development, regulatory guidelines
Lucy
Mark Engelman

Biography

Professor Mark Engelman is a specialist Intellectual property barrister, having qualified as a pharmacologist, he then qualified at the Engilsh bar and has practiced in intellectual property for 30 years. He was appointed Research Associate to St Edmund

Researches :

  • Biosimilars and Pharmacology
Lucy
Parameshwarappa Latha Kotehal
Kuvempu University, India

Biography

Dr. Latha K P received her Master of Science in Chemistry in 1989 from University of Mysore, Mysore, Karnataka, India, Later she received Ph.D. degree from the department of PG Studies and Research in Chemistry Kuvempu University in 2002. At present she i

Researches :

  • Medicinal Chemistry, Drug discovery, Synthetic organic Chemistry Bioinorganic Chemistry
Lucy
Hosadu Manjappa Vagdevi
Kuvempu University, India

Biography

Dr. H.M Vagdevi received her Master of Science in Organic Chemistry in 1983 from University of Mysore, Mysore, Karnataka, India , she received Ph.D. degree from the Department of PG Studies and Rresearch in Chemistry, Kuvempu University in 2002. She has w

Researches :

  • Synthetic Organic Chemistry and Chemistry of natural products.
Lucy
Karlheinz Landauer
MD
Quality Biotech Development Cells GmbH

Lucy
Anupam Chanda
Alembic Pharmaceuticals, India

Biography

Anupam Chanda  has his expertise in  creating innovative design in packaging material and device for Biologics, biosimilar , anti Cancer and HIV products. He is having two decades( approx. 25 years) of experience in India and abroad. He is a renowned speaker , widely travel throughout the world. Gain and share his thoughts with scientist from various institution and industry professionals. Author’s Technical book “ Packaging Technology An advance Practical approach “Published from Germany and Amazon is distributing to 77 countries.

Researches :

  • Biologics, Biosimilar, anti Cancer and HIV products
Lucy
Karlheinz Landauer
MD
Quality Biotech Development Cells GmbH

Lucy
Hosadu Manjappa Vagdevi
Kuvempu University, India

Biography

Dr. H.M Vagdevi received her Master of Science in Organic Chemistry in 1983 from University of Mysore, Mysore, Karnataka, India , she received Ph.D. degree from the Department of PG Studies and Rresearch in Chemistry, Kuvempu University in 2002. She has w

Researches :

  • Synthetic Organic Chemistry and Chemistry of natural products.
Lucy
Parameshwarappa Latha Kotehal
Kuvempu University, India

Biography

Dr. Latha K P received her Master of Science in Chemistry in 1989 from University of Mysore, Mysore, Karnataka, India, Later she received Ph.D. degree from the department of PG Studies and Research in Chemistry Kuvempu University in 2002. At present she i

Researches :

  • Medicinal Chemistry, Drug discovery, Synthetic organic Chemistry Bioinorganic Chemistry

Program Overview

NO Image
NO Image

Our Collaborations, Sponsors, Media Partners

no image no image no image no image no image no image no image no image